Skip to main content
. 2020 Feb 17;19:1533033819886896. doi: 10.1177/1533033819886896

Figure 7.

Figure 7.

Area under the curve (AUC) estimated from dynamic contrast-enhanced ultrasound (DCE-US) for control mice receiving placebo (N = 6), mice receiving sorafenib (N= 6), ziv-aflibercept (N = 8), and the 2 drugs combined (N = 7).